Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × apatinib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10 Stomach Neoplasms 6 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Ovarian Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Advanced Gastric Cancer 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Salivary Gland Neoplasms 1 Radioactive Iodine-refractory Differentiated Thyroid Cancer 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Malignant Neoplasms of Digestive Organs 1 Liver Neoplasms 1 Gestational Trophoblastic Disease 1 Gastrointestinal Stromal Tumors 1 Gastric Adenocarcinoma 1 Fludzoparib" and Anti-angiogenic 1 Colonic Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Biliary Tract Neoplasms 1 Advanced Primary Liver Cancer 1 Advanced Biliary Tract Carcinoma 1

Interventions

durvalumab 13 Bevacizumab 11 Nivolumab 10 tremelimumab 7 pembrolizumab 7 fludarabine 7 Cyclophosphamide 7 lenvatinib 6 atezolizumab 4 Radiosurgery 4 Cisplatin 4 toripalimab 3 relatlimab 3 Sorafenib 3 Ipilimumab 3 Gemcitabine 3 regorafenib 2 fludarabine phosphate 2 X-Rays 2 Riluzole 2 Radiotherapy 2 Photons 2 Patient Navigation 2 Magnetic Resonance Imaging 2 Lidocaine 2 Dexamethasone 2 Biopsy 2 zimberelimab 1 trastuzumab deruxtecan 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07105748 2025-08-17

TASK-05

Fudan University

Phase 2 Recruiting

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡